SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2012 on Wednesday, August 8, 2012, after the U.S. financial markets close. ACADIA’s management will host a conference call and webcast on Wednesday, August 8, 2012, at 5:00 p.m. Eastern Time to discuss ACADIA’s financial results and development programs.
